Pro Medicus Limited

ASX (AUD): Pro Medicus Limited (PME)

Last Price

248.79

Today's Change

-6.65 (2.60%)

Day's Change

248.70 - 254.99

Trading Volume

68,750

Overview

Market Cap

25 Billion

Shares Outstanding

104 Million

Avg Volume

256,449

Avg Price (50 Days)

220.72

Avg Price (200 Days)

155.21

PE Ratio

310.99

EPS

0.80

Earnings Announcement

13-Feb-2025

Previous Close

255.44

Open

254.99

Day's Range

248.7 - 254.99

Year Range

85.6 - 271.37

Trading Volume

68,750

Price Change Highlight

1 Day Change

-2.60%

5 Day Change

-3.19%

1 Month Change

12.19%

3 Month Change

43.62%

6 Month Change

77.09%

Ytd Change

158.35%

1 Year Change

160.21%

3 Year Change

304.41%

5 Year Change

951.52%

10 Year Change

22517.27%

Max Change

21533.91%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Health Information Services

Description:

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment